These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20372836)

  • 1. DNA oxidative damage of neoplastic rat liver lesions.
    Marengo B; De Ciusis C; Ricciarelli R; Romano P; Passalacqua M; Marinari UM; Pronzato MA; Domenicotti C
    Oncol Rep; 2010 May; 23(5):1241-6. PubMed ID: 20372836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible involvement of oxidative stress in dicyclanil-induced hepatocarcinogenesis in mice.
    Moto M; Umemura T; Okamura M; Muguruma M; Ito T; Jin M; Kashida Y; Mitsumori K
    Arch Toxicol; 2006 Oct; 80(10):694-702. PubMed ID: 16550380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of c-myc overexpression and amplification with progression of preneoplastic liver lesions to malignancy in the poorly susceptible Wistar rat strain.
    De Miglio MR; Simile MM; Muroni MR; Pusceddu S; Calvisi D; Carru A; Seddaiu MA; Daino L; Deiana L; Pascale RM; Feo F
    Mol Carcinog; 1999 May; 25(1):21-9. PubMed ID: 10331741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell cycle deregulation in liver lesions of rats with and without genetic predisposition to hepatocarcinogenesis.
    Pascale RM; Simile MM; De Miglio MR; Muroni MR; Calvisi DF; Asara G; Casabona D; Frau M; Seddaiu MA; Feo F
    Hepatology; 2002 Jun; 35(6):1341-50. PubMed ID: 12029619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ras-driven proliferation and apoptosis signaling during rat liver carcinogenesis is under genetic control.
    Calvisi DF; Pinna F; Pellegrino R; Sanna V; Sini M; Daino L; Simile MM; De Miglio MR; Frau M; Tomasi ML; Seddaiu MA; Muroni MR; Feo F; Pascale RM
    Int J Cancer; 2008 Nov; 123(9):2057-64. PubMed ID: 18697198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of oxidative damage by a glutathione-gamma-glutamyl transpeptidase system in preneoplastic lesions in sections of livers from carcinogen-treated rats.
    Stark AA; Russell JJ; Langenbach R; Pagano DA; Zeiger E; Huberman E
    Carcinogenesis; 1994 Feb; 15(2):343-8. PubMed ID: 7906207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the antioxidant defense and hepatic drug metabolizing enzyme and isoenzyme levels, 8-hydroxydeoxyguanosine formation and expressions of c-raf.1 and insulin-like growth factor II genes during the stages of development of hepatocellular carcinoma in rats.
    Mukherjee B; Das T; Ghosh S; Datta S
    Eur J Cancer Prev; 2007 Aug; 16(4):363-71. PubMed ID: 17554210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.
    Frau M; Ladu S; Calvisi DF; Simile MM; Bonelli P; Daino L; Tomasi ML; Seddaiu MA; Feo F; Pascale RM
    J Hepatol; 2011 Jul; 55(1):111-9. PubMed ID: 21419759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis.
    Kowalik MA; Guzzo G; Morandi A; Perra A; Menegon S; Masgras I; Trevisan E; Angioni MM; Fornari F; Quagliata L; Ledda-Columbano GM; Gramantieri L; Terracciano L; Giordano S; Chiarugi P; Rasola A; Columbano A
    Oncotarget; 2016 May; 7(22):32375-93. PubMed ID: 27070090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous bone marrow cell infusions suppress tumor initiation in hepatocarcinogenic mice with liver cirrhosis.
    Maeda M; Takami T; Terai S; Sakaida I
    J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2():104-11. PubMed ID: 22320927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clear cell hepatocellular carcinoma: origin, metabolic traits and fate of glycogenotic clear and ground glass cells.
    Bannasch P; Ribback S; Su Q; Mayer D
    Hepatobiliary Pancreat Dis Int; 2017 Dec; 16(6):570-594. PubMed ID: 29291777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of fenofibrate on oxidative DNA damage and on gene expression related to cell proliferation and apoptosis in rats.
    Nishimura J; Dewa Y; Muguruma M; Kuroiwa Y; Yasuno H; Shima T; Jin M; Takahashi M; Umemura T; Mitsumori K
    Toxicol Sci; 2007 May; 97(1):44-54. PubMed ID: 17264098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indole-3-carbinol enhances oxidative stress responses resulting in the induction of preneoplastic liver cell lesions in partially hepatectomized rats initiated with diethylnitrosamine.
    Shimamoto K; Dewa Y; Ishii Y; Kemmochi S; Taniai E; Hayashi H; Imaoka M; Morita R; Kuwata K; Suzuki K; Shibutani M; Mitsumori K
    Toxicology; 2011 May; 283(2-3):109-17. PubMed ID: 21396975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation during early hepatocarcinogenesis: cellular and molecular effects.
    Chagas CE; Bassoli BK; de Souza CA; Deminice R; Jordão Júnior AA; Paiva SA; Dagli ML; Ong TP; Moreno FS
    Int J Cancer; 2011 Nov; 129(9):2073-82. PubMed ID: 21480218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular and metabolic changes in human clear cell liver foci].
    Ribback S; Calvisi DF; Cigliano A; Rausch J; Heidecke CD; Birth M; Dombrowski F
    Pathologe; 2015 Nov; 36 Suppl 2():210-5. PubMed ID: 26483250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple adaptive mechanisms to chronic liver disease revealed at early stages of liver carcinogenesis in the Mdr2-knockout mice.
    Katzenellenbogen M; Pappo O; Barash H; Klopstock N; Mizrahi L; Olam D; Jacob-Hirsch J; Amariglio N; Rechavi G; Mitchell LA; Kohen R; Domany E; Galun E; Goldenberg D
    Cancer Res; 2006 Apr; 66(8):4001-10. PubMed ID: 16618719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nelumbo nucifera leaf extract treatment attenuated preneoplastic lesions and oxidative stress in the livers of diethylnitrosamine-treated rats.
    Horng CT; Huang CW; Yang MY; Chen TH; Chang YC; Wang CJ
    Environ Toxicol; 2017 Nov; 32(11):2327-2340. PubMed ID: 28804948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokeratin-19 positivity is acquired along cancer progression and does not predict cell origin in rat hepatocarcinogenesis.
    Kowalik MA; Sulas P; Ledda-Columbano GM; Giordano S; Columbano A; Perra A
    Oncotarget; 2015 Nov; 6(36):38749-63. PubMed ID: 26452031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC.
    Calvisi DF; Pinna F; Ladu S; Pellegrino R; Simile MM; Frau M; De Miglio MR; Tomasi ML; Sanna V; Muroni MR; Feo F; Pascale RM
    Gut; 2009 May; 58(5):679-87. PubMed ID: 19136513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible involvement of oxidative stress in fenofibrate-induced hepatocarcinogenesis in rats.
    Nishimura J; Dewa Y; Okamura T; Muguruma M; Jin M; Saegusa Y; Umemura T; Mitsumori K
    Arch Toxicol; 2008 Sep; 82(9):641-54. PubMed ID: 18253720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.